MRT-3 offers commuters free antigen testing for the second time | Inquirer News

MRT-3 offers commuters free antigen testing for the second time

/ 11:09 AM February 02, 2022

MRT-3 offers commuters free antigen testing for the second time

Free antigen testing is available anew during weekdays at select MRT-3 stations. INQUIRER file photo / Niño Jesus Orbeta

MANILA, Philippines – The Department of Transportation (DOTr) launched its second round of free antigen testing through Metro Rail Transit Line 3 (MRT-3) at no cost to commuters willing to test for COVID-19.

According to an MRT statement, the measure is part of the organization’s efforts to protect commuters from the spread of SARS-CoV-2, the virus that causes COVID-19.

Article continues after this advertisement

Free antigen testing is available during weekdays in two separate time frames—8 a.m. to 9 a.m. and 5:00 p.m. to 6:00 p.m—in the following MRT stations:

FEATURED STORIES

• North Avenue

• Cubao

Article continues after this advertisement

• Shaw Boulevard

Article continues after this advertisement

• Taft Avenue

Article continues after this advertisement

DOTr MRT-3 posted guidelines that require passengers who wish to avail themselves of free antigen testing to complete one consent form and receive a free ride once they test negative.

READ: DOTr to do random COVID testing on LRT, MRT passengers; trains still at 70% capacity

Article continues after this advertisement

“Kinakailangan lamang lumapit ng mga boluntaryong pasahero sa testing areas sa mga istasyon at sabihing nais magpa-antigen test. Isang consent form ang ibibigay sa pasahero upang punan. Libreng makasasakay ng MRT-3 ang pasaherong magboboluntaryo sa random antigen testing at magne-negatibo ang resulta sa test,” the management said.

(Antigen testing is free for those who visit the testing station and declare their interest. Passengers will be given only one consent form to complete. As long as the passenger tests negative for the virus, a free ride will be given to them.)

As soon as the results turn positive, the management has indicated that it will ground the passenger and advise them to self-isolate and to contact their respective local government units (LGUs) for further monitoring.

“Sa oras naman na magpositibo sa antigen testing ang pasahero, hindi na ito papasakayin ng tren at aabisuhan na kaagad magself-isolate at makipag-ugnayan sa local government unit (LGU) para sa health monitoring at confirmatory RT-PCR testing,” the management announced.

(If the antigen test of the passenger tested positive, they are prohibited from riding the train and will be advised to self-isolate and communicate with the local government unit for health monitoring and confirmatory RT-PCR testing.)

MRT-3 management will continue to provide free antigen testing until further notice.

The first round of free random antigen screenings for MRT-3 was conducted from January 11 to 31.

READ: MRT-3 starts random COVID-19 antigen testing for passengers

As of Tuesday, the country registered 9,493 new confirmed cases of COVID-19, adding to the total caseload of 3, 569, 665.

READ: 9,493 new COVID-19 cases recorded, lowest since January 5

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Jericho Zafra, trainee

/abc

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: antigen test, COVID-19, DoTr, MRT, Transport

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.